title: Bone metastases: Are we failing our patients?
authors.affiliation: Cliniques Universitaires Saint-Luc, 10 Avenue Hippocrate, B-1200 Brussels, Belgium.
authors.forename: B
authors.initials: B
authors.lastname: Tombal
authors.affiliation: CGG-Klinik Mannheim, Gynäkologischer Onkologe, Quadrat P7, 16-18, 68161 Mannheim, Germany.
authors.forename: I
authors.initials: I
authors.lastname: Diel
authors.affiliation: Department of Urology, King׳s College Hospital NHS Foundation Trust, London, UK.
authors.forename: L
authors.initials: L
authors.lastname: Drudge-Coates
authors.affiliation: Amgen Ltd, Uxbridge, UK.
authors.forename: I
authors.initials: I
authors.lastname: Haynes
authors.affiliation: Comprehensive Cancer Center - Muscoloskeletal Tumors, General Hospital of Vienna, Medical University of Vienna, Vienna, Austria.
authors.forename: T
authors.initials: T
authors.lastname: Brodowicz
keywords: Bisphosphonates; Bone metastases; Bone-targeted agents; Denosumab; SRE, skeletal related event; Skeletal-related events